The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban

被引：1

作者：

Kim, Young-Hoon ^{[1
]}

Shim, Jaemin ^{[1
]}

Tsai, Chia-Ti ^{[2
]}

Wang, Chun-Chieh ^{[3
]}

Vilela, Gilbert ^{[4
]}

Muengtaweepongsa, Sombat ^{[5
]}

Kurniawan, Mohammad ^{[6
]}

Maskon, Oteh ^{[7
]}

Hsu, Li Fern ^{[8
]}

Thang Huy Nguyen ^{[9
]}

Sim, Kenneth ^{[10
]}

Camm, A. John ^{[11
,12
]}

机构：

[1] Korea Univ, Med Ctr, Seoul, South Korea

[2] Natl Taiwan Univ Hosp, Taipei, Taiwan

[3] Chang Gung Univ, Chang Gung Mem Hosp, Taoyuan, Taiwan

[4] Philippine Heart Ctr, Quezon City, Philippines

[5] Thammasat Univ, Stroke Excellence Ctr, Fac Med, Pathum Thani, Thailand

[6] Univ Indonesia, Dept Neurol, Cipto Mangunkusumo Natl Hosp, Fac Med, Jakarta, Indonesia

[7] Natl Univ Malaysia, Dept Med, Med Ctr, Kuala Lumpur, Malaysia

[8] Mt Elizabeth Novena Specialist Ctr, Novena Heart Ctr, Singapore, Singapore

[9] Pham Ngoc Thach Med Univ, Dept Neurol, Ho Chi Minh City, Vietnam

[10] Bayer South East Asia Pte Ltd, Singapore, Singapore

[11] Univ London, Cardiol Clin Acad Grp St Georges, London, England

[12] Imperial Coll, London, England

来源：

CHEST | 2019年 / 155卷 / 06期

关键词：

ANTAGONIST ORAL ANTICOAGULANTS; STROKE PREVENTION; WARFARIN; DABIGATRAN; ASIANS;

D O I：

10.1016/j.chest.2019.03.036

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1309 / 1311

页数：4

共 50 条

[41] Atrial fibrillation, thromboembolism and antithrombotic therapy
Li-Saw-Hee, FL
Lip, GYH
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, 53 (02) : 110 - 117
[42] ANTITHROMBOTIC THERAPY IN ATRIAL-FIBRILLATION
LAUPACIS, A
ALBERS, G
DUNN, M
FEINBERG, W
CHEST, 1992, 102 (04) : S426 - S444
[43] Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, Mikhail S.
Lip, Gregory Y. H.
CARDIOLOGY CLINICS, 2014, 32 (04) : 585 - +
[44] Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, Mikhail S.
Lip, Gregory Y. H.
HEART FAILURE CLINICS, 2016, 12 (02) : 257 - +
[45] Antithrombotic therapy: Is combination antithrombotic therapy safe for patients with atrial fibrillation?
Myrvang H.
Nature Reviews Cardiology, 2010, 7 (12) : 665 - 665
[46] Chest physicians issue guidelines on antithrombotic therapy
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1490 - 1492
[47] Antithrombotic Therapy for Atrial Fibrillation Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
You, John J.
Singer, Daniel E.
Howard, Patricia A.
Lane, Deirdre A.
Eckman, Mark H.
Fang, Margaret C.
Hylek, Elaine M.
Schulman, Sam
Go, Alan S.
Hughes, Michael
Spencer, Frederick A.
Manning, Warren J.
Halperin, Jonathan L.
Lip, Gregory Y. H.
CHEST, 2012, 141 (02) : E531S - E575S
[48] Newly detected atrial fibrillation and compliance with antithrombotic guidelines
Glazer, Nicole L.
Dublin, Sascha
Smith, Nicholas L.
French, Benjamin
Jackson, Lisa A.
Hrachovec, Jennifer B.
Siscovick, David S.
Psaty, Bruce M.
Heckbert, Susan R.
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (03) : 246 - 252
[49] Newly detected atrial fibrillation and compliance with antithrombotic guidelines
Glazer, NL
Dublin, S
Smith, NL
French, B
Jackson, LA
Siscovick, DS
Psaty, BM
Heckbert, SR
CIRCULATION, 2006, 113 (08) : E313 - E313
[50] Outcomes of Rivaroxaban as Part of Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
Alshahrani, Asma
Alshareef, Hanan
Alanazi, Zaid
Alsawaq, Enas
LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (05): : 917 - 922

← 1 2 3 4 5 →